SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ANDRX (ADRX)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: PAUL ROBERT ST. ONGE who wrote (28)9/17/1997 1:53:00 PM
From: Czechsinthemail   of 127
 
Paul,

Do you have any idea when Dilacor approval might happen? The pipeline for ADRX looks extremely strong. I like companies like this that can provide enhanced delivery systems, because it provides a much greater predictability on getting FDA approval and getting drugs to market.

Another drug delivery company you might be interested in is Depotech (DEPO). They have a major cancer drug DepoCyt on the verge of FDA approval.

Good luck,

Baird
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News